enzalutamide
pfizer,astellas
['enzamet']
dr. updated the results of #enzamet trial with subgroup analysis according to volume, timing of metastatic disease and concomitant docetaxel use. imo, showing that docetaxel adds no benefit to adt + enzalutamide, defying in this case the triple therapy. #asco22 
Medical oncologist at @BPorgbr. Former fellow of GU oncology @DanaFarber @Harvard @MOCbrasil. #GUcancer